DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Mok T, Wu YL, Lee JS. et al.
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.
Clin Cancer Res 2015;
21: 3196-3203
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.